Company No: 11697914 (England and Wales)

Contents

• Balance Sheet

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 11697914). The address of its registered office is 264 Banbury Road, Oxford, OX2 7DY, United Kingdom.

2. Employees

3. Directors’ benefits: advances, credit and guarantees

Advances

At the year end, the company owed the director £2,757 (2024: £6,369 was owed by the director). No interest was charged on the amount owed by the director. The balance is repayable on demand.

For the financial year ending 30 November 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
• These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
• These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Genomic Medicine Services Ltd (registered number: 11697914) were approved and authorised for issue by the director on 18 August 2026 and were signed on its behalf by: